Suppr超能文献

莪术醇靶向FTO/MAFG-AS1轴以减轻糖尿病视网膜病变的表观遗传重塑和基于纳米递送的微环境调节。

Curcumol targets the FTO/MAFG-AS1 axis to alleviate diabetic retinopathy epigenetic remodeling and nanodelivery-based microenvironment modulation.

作者信息

Luo Cheng, Zheng Zhi-Gang, Zeng Mei-Qi, Xu Hui, Yu Xian-Mei, Sun Da, He Dong-Juan

机构信息

Department of Endocrinology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, Zhejiang Province, China.

Department of Ophthalmology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, Zhejiang Province, China.

出版信息

World J Diabetes. 2025 Jun 15;16(6):107017. doi: 10.4239/wjd.v16.i6.107017.

Abstract

Diabetic retinopathy (DR) is a major microvascular complication of diabetes, with its pathogenesis involving metabolic memory, epigenetic dysregulation, and multi-cellular microenvironmental disorders. This study systematically investigates the mechanism by which curcumol ameliorates DR through regulation of the FTO/MAFG-AS1 epigenetic axis and reveals its therapeutic potential in targeting the retinal microenvironment a nano-delivery system. Experimental results demonstrate that curcumol activates the demethylase activity of FTO, stabilizing the expression of the long non-coding RNA MAFG-AS1, thereby inhibiting high glucose-induced retinal endothelial cell inflammation, migration, and vascular leakage. Single-cell transcriptomic analysis further uncovered the dual role of FTO in DR: On the one hand, it promotes pathological angiogenesis in endothelial cells, while on the other hand, it exerts protective effects through MAFG-AS1-mediated antioxidative and anti-inflammatory functions. Moreover, this study proposes a multidimensional epigenetic regulatory network based on histone lactylation, N6-methyladenosine modification, and DNA methylation, and verifies that curcumol delays DR progression by coordinately modulating these modifications. To overcome the limitations of conventional therapies, this study innovatively designed a macrophage membrane-coated nano-delivery system, significantly enhancing the retinal targeting and bioavailability of curcumol. Finally, the study advocates a paradigm shift from passive treatment to early prevention, proposing a three-tiered intervention strategy that integrates epigenetic biomarkers with artificial intelligence-based risk assessment. These findings not only elucidate the multi-target regulatory mechanisms of curcumol but also provide a theoretical foundation for the development of precision therapies for DR based on epigenetic remodeling and microenvironmental synergistic intervention.

摘要

糖尿病视网膜病变(DR)是糖尿病的一种主要微血管并发症,其发病机制涉及代谢记忆、表观遗传失调和多细胞微环境紊乱。本研究系统地探讨了莪术醇通过调节FTO/MAFG-AS1表观遗传轴改善DR的机制,并揭示了其在靶向视网膜微环境的纳米递送系统中的治疗潜力。实验结果表明,莪术醇激活FTO的去甲基化酶活性,稳定长链非编码RNA MAFG-AS1的表达,从而抑制高糖诱导的视网膜内皮细胞炎症、迁移和血管渗漏。单细胞转录组分析进一步揭示了FTO在DR中的双重作用:一方面,它促进内皮细胞的病理性血管生成,另一方面,它通过MAFG-AS1介导的抗氧化和抗炎功能发挥保护作用。此外,本研究提出了一个基于组蛋白乳酰化、N6-甲基腺苷修饰和DNA甲基化的多维表观遗传调控网络,并验证了莪术醇通过协同调节这些修饰来延缓DR的进展。为了克服传统疗法的局限性,本研究创新性地设计了一种巨噬细胞膜包被的纳米递送系统,显著提高了莪术醇的视网膜靶向性和生物利用度。最后,该研究倡导从被动治疗向早期预防的范式转变,提出了一种将表观遗传生物标志物与基于人工智能的风险评估相结合的三层干预策略。这些发现不仅阐明了莪术醇的多靶点调控机制,也为基于表观遗传重塑和微环境协同干预的DR精准治疗的发展提供了理论基础。

相似文献

3
Fenofibrate for diabetic retinopathy.
Cochrane Database Syst Rev. 2023 Jun 13;6(6):CD013318. doi: 10.1002/14651858.CD013318.pub2.
5
Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.
Cochrane Database Syst Rev. 2011 Jul 6(7):CD008081. doi: 10.1002/14651858.CD008081.pub2.
6
Home treatment for mental health problems: a systematic review.
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
7
Management of urinary stones by experts in stone disease (ESD 2025).
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Systematic review on urine albumin testing for early detection of diabetic complications.
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.

本文引用的文献

2
Narrative review of comprehensive management strategies for diabetic retinopathy: interdisciplinary approaches and future perspectives.
BMJ Public Health. 2025 Jan 16;3(1):e001353. doi: 10.1136/bmjph-2024-001353. eCollection 2025 Jan.
3
The prevention opportunities of retinopathy in diabetic patients - position paper endorsed by the Polish Lipid Association.
Arch Med Sci. 2024 Dec 13;20(6):1754-1769. doi: 10.5114/aoms/197331. eCollection 2024.
5
RNA methylation homeostasis in ocular diseases: All eyes on Me.
Prog Retin Eye Res. 2025 Mar;105:101335. doi: 10.1016/j.preteyeres.2025.101335. Epub 2025 Jan 27.
6
FTO in health and disease.
Front Cell Dev Biol. 2024 Dec 18;12:1500394. doi: 10.3389/fcell.2024.1500394. eCollection 2024.
7
Multi-omics in exploring the pathophysiology of diabetic retinopathy.
Front Cell Dev Biol. 2024 Dec 11;12:1500474. doi: 10.3389/fcell.2024.1500474. eCollection 2024.
8
Autophagy-dependent ferroptosis may play a critical role in early stages of diabetic retinopathy.
World J Diabetes. 2024 Nov 15;15(11):2189-2202. doi: 10.4239/wjd.v15.i11.2189.
9
Update: the role of epigenetics in the metabolic memory of diabetic complications.
Am J Physiol Renal Physiol. 2024 Sep 1;327(3):F327-F339. doi: 10.1152/ajprenal.00115.2024. Epub 2024 Jul 4.
10
Reversal of high-glucose-induced transcriptional and epigenetic memories through NRF2 pathway activation.
Life Sci Alliance. 2024 May 16;7(8). doi: 10.26508/lsa.202302382. Print 2024 Aug.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验